Ero Copper Corp (ERO)vsStryker Corporation (SYK)
ERO
Ero Copper Corp
$28.48
+5.09%
BASIC MATERIALS · Cap: $2.83B
SYK
Stryker Corporation
$285.47
-2.98%
HEALTHCARE · Cap: $112.69B
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 2635% more annual revenue ($25.27B vs $923.93M). ERO leads profitability with a 31.6% profit margin vs 13.2%. ERO trades at a lower P/E of 9.7x. ERO earns a higher WallStSmart Score of 78/100 (B+).
ERO
Strong Buy78
out of 100
Grade: B+
SYK
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+7.2%
Fair Value
$33.93
Current Price
$28.48
$5.45 discount
Margin of Safety
-10.9%
Fair Value
$265.23
Current Price
$285.47
$20.24 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Every $100 of equity generates 33 in profit
Keeps 32 of every $100 in revenue as profit
Strong operational efficiency at 34.7%
Revenue surging 110.4% year-over-year
Reasonable price relative to book value
Large-cap with strong market position
Areas to Watch
No major concerns identified
Premium valuation, high expectations priced in
2.6% revenue growth
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : ERO
The strongest argument for ERO centers on P/E Ratio, Return on Equity, Profit Margin. Profitability is solid with margins at 31.6% and operating margin at 34.7%. Revenue growth of 110.4% demonstrates continued momentum.
Bull Case : SYK
The strongest argument for SYK centers on Market Cap. PEG of 1.39 suggests the stock is reasonably priced for its growth.
Bear Case : ERO
No major red flags identified for ERO, but monitor valuation.
Bear Case : SYK
The primary concerns for SYK are P/E Ratio, Revenue Growth, Piotroski F-Score.
Key Dynamics to Monitor
ERO profiles as a growth stock while SYK is a value play — different risk/reward profiles.
ERO carries more volatility with a beta of 1.56 — expect wider price swings.
ERO is growing revenue faster at 110.4% — sustainability is the question.
SYK generates stronger free cash flow (415M), providing more financial flexibility.
Bottom Line
ERO scores higher overall (78/100 vs 59/100), backed by strong 31.6% margins and 110.4% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ero Copper Corp
BASIC MATERIALS · COPPER · USA
Ero Copper Corp. The company is headquartered in Vancouver, Canada.
Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Compare with Other COPPER Stocks
Want to dig deeper into these stocks?